O-39 HER2 positive early breast cancers: What proportion are receiving adjuvant Trastuzumab therapy? A multicentre audit

✍ Scribed by S. Marla; J. Cardale; D.J. Dodwell; A.I. Skene; O. Gojis; P. Abram; C. Palmieri; S.J. Cleator; A. Bowman; J.C. Doughty

• Book ID: 119233750
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 42 KB
• Volume: 8
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/j.ejcsup.2010.06.040